Active, Not Recruiting
Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
NCT02598661
- Conditions
- Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +5 more
- Locations
-
- UAB Comprehensive Cancer Center Birmingham, Alabama, United States
- Acrc/Arizona Clinical Research, Inc. Tucson, Arizona, United States
- CBCC Global Research, Inc. Bakersfield, California, United States
- UCLA Ronald Regan Medical Center Los Angeles, California, United States